Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00676312 | Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects | PHASE1 | COMPLETED | 32 | — | — | May 1, 2008 | - | Dec 11, 2008 | 1 | Switzerland |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Cross-over treatment with increasing doses of PTH134, placebo and active comparator. |
| Name | Type | Description |
|---|---|---|
| PTH134 | DRUG | - |
Inclusion Criteria: * Healthy postmenopausal female subjects, 40 to 70 years of age and in good health as determined by past medical history, physical examination, vital signs, electrocardiogram, and laboratory tests at screening * Body mass index (BMI) within the range of 19 to 32. Exclusion Crit...